Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Iran J Pathol ; 17(3): 268-274, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36247506

RESUMEN

Background & Objective: Metaplastic carcinoma is a diverse variant of invasive breast carcinomas (IBC) characterized by dedifferentiation of malignant cells towards squamous and/or mesenchymal elements. It accounts for 0.3-1.2% of all IBC. These tumors are typically triple-negative by hormonal profiling with a high proliferation index and a dismal prognosis. Lymph node metastasis is an unusual feature in metaplastic carcinoma. Methods: The present study analyses 30 cases (26 cases of modified radical mastectomy and 4 cases of lumpectomy) of metaplastic carcinoma over 2018-2020 (3 years). Four oncopathologists reviewed routine histopathologic and immunohistochemical-stained slides. The clinical details were collected from the Medical Records Department of the Cancer Institute. Results: A total of 20 (66.67%) cases were patients >50 years of age, 21(70%) out of which were diagnosed as invasive carcinoma, grade 3 according to the Nottingham histological score. Five (16.7%) cases presented with lymph node metastasis. While immunohistochemically 28 (93.3%) cases were triple-negativeCK5/6, P63, EGFR, and Ki-67 (more than 40%) positivity was noted in 25 (83.3%) , 26 (86,7%) , 20 (66.7%), and 25 (83.3%) cases, respectively. Conclusion: Metaplastic carcinoma is characteristically triple-negative breast malignancies (TNBC) exhibiting a high Ki-67 index and a lower rate of lymph node metastasis. CK5/6, p63, and EGFR are pertinent immunohistochemical markers that may aid in diagnosis. However, those markers are non-specific for the disease and morphologic features are always the key to diagnosis of the process.

2.
Acta Crystallogr E Crystallogr Commun ; 71(Pt 6): o382, 2015 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-26090178

RESUMEN

In the title compound, C17H10F3NS, the dihedral angle between the fused benzo-thio-phene ring system (r.m.s. deviation = 0.042 Å) and the benzene ring is 29.78 (11)°. The crystal structure features C-H⋯F and very weak C-H⋯N hydrogen bonds, which generate (001) sheets.

3.
Acta Crystallogr E Crystallogr Commun ; 71(Pt 2): o74, 2015 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-25878878

RESUMEN

In the title compound, C15H13NS, the thia-zine ring adopts a boat conformation. The dihedral angle between the planes of the benzene ring of the benzo-thia-zine unit and the tolyl ring is 19.52 (9)°. In the crystal, mol-ecules are linked by weak C-H⋯π inter-actions into a tape structure along the b-axis direction.

4.
Ann Hum Biol ; 42(1): 97-100, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25117664

RESUMEN

BACKGROUND: Dihydropyrimidine dehydrogenase (DPD) encoded by DPYD gene is the major enzyme involved in metabolism of 5-flurouracil (5-FU), a pyrimidine analogue used in cancer chemotherapy. Although very effective as a cancer therapeutic drug, if not rapidly metabolized, 5-FU may prove lethal. Single nucleotide variants (SNVs) within DPYD that modulate DPD enzyme activity contribute to 5-FU toxicity. STUDY: This study looked for DPYD SNVs common in the Indian population that might be associated with variable DPD activity and drug toxicity. To achieve this, sequencing analysis was performed of all 23 exons and flanking intronic regions of the DPYD gene in a cohort of 50 healthy adult Indians. This study detected 22 SNVs including intronic, synonymous and non-synonymous changes in the DPYD gene, of which six have not been documented before. Allelic frequency was calculated for the observed variants and linkage disequilibrium (LD) analysis was performed on variants with frequency ≥0.1 to identify haplotypes. CONCLUSIONS: This study provides a brief overview of the genetic polymorphism in DPYD in Indians and emphasizes the need for a large scale extensive study to establish markers associated with the frequently observed variable drug metabolism.


Asunto(s)
Dihidrouracilo Deshidrogenasa (NADP)/genética , Fluorouracilo/metabolismo , Adulto , Secuencia de Bases , Femenino , Fluorouracilo/toxicidad , Frecuencia de los Genes , Humanos , Inactivación Metabólica , India , Masculino , Polimorfismo Genético , Análisis de Secuencia de ADN , Población Blanca/genética
5.
Gene ; 524(1): 35-9, 2013 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-23612254

RESUMEN

Cytidine deaminase (CDA) is the major enzyme involved in metabolism of gemcitabine, a pyrimidine analog widely used for chemotherapy of solid tumors. While only low amounts of administered gemcitabine undergo intracellular phosphorylation into active forms and involve in antineoplastic activities, majority of it is rapidly inactivated by CDA and excreted to avoid drug toxicity. Knowledge of the genetic polymorphisms mildly effecting cellular activity of the enzyme CDA is therefore crucial to understanding drug-induced toxicities associated with gemcitabine. Functional significance and allele frequencies for common SNPs including 79A>C (*2) and 208G>A (*3) have been reported in various ethnic populations including Caucasian, African, Korean and Japanese. However, such studies have not been reported in any Indian sub-population. In the present study, conventional polymerase chain reaction (PCR) based amplification using gene specific primers and Sanger sequencing were performed to identify CDA variants in 50 healthy individuals from Indian sub-population. Established common variant 79A>C known to reduce CDA activity was observed at a frequency of 0.14 in the study cohort. In addition to other known variants, one novel variant, c.325-209T>C was detected at a frequency of 0.06. Genetic variants in CDA gene and their frequencies established in our study hold value in pharmacogenetics.


Asunto(s)
Pueblo Asiatico/genética , Citidina Desaminasa/genética , Etnicidad/genética , Polimorfismo de Nucleótido Simple , Adulto , Estudios de Cohortes , Análisis Mutacional de ADN , Activación Enzimática , Frecuencia de los Genes , Marcadores Genéticos , Genética de Población , Humanos , India , Intrones , Neoplasias/enzimología , Neoplasias/genética , Proyectos Piloto , Reacción en Cadena de la Polimerasa
6.
Genet Test Mol Biomarkers ; 17(3): 188-94, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23216273

RESUMEN

AIMS: Drug-metabolizing enzymes play a major role in determining the outcome of drug therapy. N-acetyltransferase-2 (NAT2) is one of the main enzymes involved in metabolism of isoniazid used in treatment of tuberculosis (TB). Several variations in the NAT2 gene give rise to multiple haplotypes that phenotypically code for different acetylator status. The objective was to generate a more unambiguous picture of the NAT2 scenario in India as compared to that obtained from polymerase chain reaction-restriction fragment length polymorphism methods. METHODS: Full-gene-sequencing analysis of NAT2 was carried out in 181 healthy Indian subjects from different regional groups. RESULTS: A total of 33 diplotypes were recorded from six known single-nucleotide polymorphisms. The overall frequency of the slow acetylator haplotypes detected in this study was 65%, followed by 26% and 9% intermediate and rapid acetylators, respectively. Of the slow acetylator alleles, the NAT2*5B/*6A occurred in 25% of the study subjects. CONCLUSIONS: The study indicates that the frequency of slow acetylator alleles is high in the adult Indian population. Since the prevalence of TB is high in this population, pharmacogenetic testing for NAT2 alleles may be advisable before start of therapy with isoniazid to prevent drug toxicity.


Asunto(s)
Arilamina N-Acetiltransferasa/genética , Genética de Población , Genotipo , Haplotipos , Humanos , India , Desequilibrio de Ligamiento , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Polimorfismo de Nucleótido Simple
7.
Biochem Genet ; 50(9-10): 684-93, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22580794

RESUMEN

Purine and pyrimidine antimetabolites are used to treat leukemias, autoimmune diseases, and solid tumors. Detection of slow metabolizers before administration of the drugs is necessary to prevent any subsequent drug toxicity. With this aim, we determined the frequencies of normal and slow alleles in our population. Polymorphisms in genes encoding cytidine deaminase (CDA), dihydropyrimidine dehydrogenase (DPYD), and thiopurine-S-methyltransferase (TPMT) were documented in 225 healthy volunteers. The polymorphisms typed included CDA*3, DPYD*2A, TPMT*2A, TPMT*3B, and TPMT*3C. Methods used for genotyping included standard PCR-RFLP and allele-specific PCR reactions. The frequencies were 0.44 % for DPYD*2A, 0.67 % for TPMT*3B, and 0.89 % for TPMT*3C. The CDA*3 and TPMT*2A alleles were not detected. Although these polymorphisms have been demonstrated to be associated with drug toxicity in other populations, they appear to be very rare in the adult Indian population.


Asunto(s)
Citidina Desaminasa/genética , Dihidrouracilo Deshidrogenasa (NADP)/genética , Frecuencia de los Genes , Metiltransferasas/genética , Purinas/antagonistas & inhibidores , Pirimidinas/antagonistas & inhibidores , Adolescente , Adulto , Alelos , Pueblo Asiatico/genética , Activación Enzimática , Femenino , Genética de Población/métodos , Genotipo , Técnicas de Genotipaje , Humanos , India , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Polimorfismo de Longitud del Fragmento de Restricción , Prevalencia , Adulto Joven
8.
Gene Expr ; 15(2): 75-87, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21526718

RESUMEN

Glucose-regulated 94 kDa protein (Grp94) is a resident of the endoplasmic reticulum (ER) of multicellular eukaryotes. It is a constitutively expressed protein that is overexpressed in certain abnormal conditions of the cell such as depletion of glucose and calcium, and low oxygen and pH. The protein is also implicated in diseased conditions like cancer and Alzheimer's disease. In this study, the consequences of downregulation of Grp94 were investigated at both unicellular and multicellular stages of Dictyostelium discoideum. Previous studies have shown the expression of Dd-Grp94 (Dictyostelium discoideum glucose-regulated 94 kDa protein) in wild-type cells varies during development, and overexpression of Dd-Grp94 leads to abnormal cell shape and inhibition of development (i.e., formation of fruiting bodies). Grp94 is a known calcium binding protein and an efficient calcium buffer. Therefore, in the present study we hypothesized that downregulation of Dd-Grp94 protein would affect Dictyostelium cell structure, growth, and development. We found that Dd-grp94 RNAi recombinants exhibited reduced growth rate, cell size, and a subtle change in cell motility compared to the parental cells. The recombinants also exhibited a delay in development and small fruiting bodies. These results establish that Dd-grp94 plays a crucial role in determining normal cell structure, growth and differentiation.


Asunto(s)
Dictyostelium/crecimiento & desarrollo , Dictyostelium/genética , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Crecimiento y Desarrollo/efectos de los fármacos , Proteínas HSP70 de Choque Térmico/antagonistas & inhibidores , Proteínas de la Membrana/antagonistas & inhibidores , ARN Interferente Pequeño/farmacología , Línea Celular , Proliferación Celular/efectos de los fármacos , Tamaño de la Célula/efectos de los fármacos , Dictyostelium/citología , Dictyostelium/efectos de los fármacos , Regulación hacia Abajo , Silenciador del Gen/fisiología , Crecimiento y Desarrollo/genética , Proteínas HSP70 de Choque Térmico/genética , Proteínas de la Membrana/genética , Modelos Biológicos , Organismos Modificados Genéticamente , Factores de Tiempo
9.
Indian J Med Res ; 111: 95-102, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10937385

RESUMEN

A single page physical activity questionnaire was designed for use in epidemiological studies. The questionnaire estimates 24 h energy expenditure as well as components of occupation and discretionary leisure time activities. Estimates of physical activity were highly repeatable, when the questionnaire was re-administered within a 4 wk period (e.g., r = 0.86, P < 0.01 for 24 h energy expenditure). Relative validity was assessed by comparing energy intake (using repeated 24 h dietary recalls) and expenditure (using the physical activity questionnaire) over the same period. A correlate of r = 0.33, P < 0.05 between the two measures compared well with reports from literature. The discriminatory power of the questionnaire was assessed by comparing the physical activity patterns of young (18-30 yr) and older (> 60 yr), free living healthy subjects. The questionnaire provides a tool for the assessment of physical activity patterns of urban middle class Indians, which despite its importance has been inadequately studied so far.


Asunto(s)
Estudios Epidemiológicos , Ejercicio Físico , Encuestas y Cuestionarios , Población Urbana , Adolescente , Adulto , Femenino , Humanos , India , Masculino , Persona de Mediana Edad , Clase Social
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA